Trials / Conditions / Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma

Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma

6 registered clinical trials studyying Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma.

Status	Trial	Sponsor	Phase
Completed	Romidepsin and Parsaclisib for the Treatment of Relapsed or Refractory T-Cell Lymphomas NCT04774068	Walter Hanel	Phase 1
Active Not Recruiting	Pembrolizumab and Pralatrexate in Treating Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas NCT03598998	City of Hope Medical Center	Phase 1 / Phase 2
Completed	Venetoclax and Romidepsin in Treating Patients With Recurrent or Refractory Mature T-Cell Lymphoma NCT03534180	City of Hope Medical Center	Phase 2
Completed	Pembrolizumab and External Beam Radiation Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin NCT03210662	M.D. Anderson Cancer Center	Phase 2
Active Not Recruiting	Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractor NCT02978625	National Cancer Institute (NCI)	Phase 2
Active Not Recruiting	Anti-ICOS Monoclonal Antibody MEDI-570 in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymp NCT02520791	National Cancer Institute (NCI)	Phase 1